WHI memory study fails to find oestrogen benefit in dementia

Journal of the British Menopause Society

Volumn 10, Issue 3, 2004, Pages 93-

  Brown, Simon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGE; AGED; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DRUG CONTRAINDICATION; DRUG USE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEMORY CONSOLIDATION; META ANALYSIS; NOTE; POSTMENOPAUSE; RECALL; RISK ASSESSMENT; RISK REDUCTION; SPATIAL ORIENTATION; SYSTEMATIC REVIEW; THINKING; TIME PERCEPTION; TREATMENT FAILURE; VERBAL BEHAVIOR; WRITING;

DEMENTIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; WOMEN'S HEALTH;

EID: 9244258650     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-2958.
2. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2959-2968.
3. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women. JAMA 2003; 289: 2663-2672.
4. Schneider LS. Estrogen and dementia: insights from the Women's Health Initiative Memory Study. JAMA 2004; 291: 3005-3007.